Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

74.11
-1.2400-1.65%
Pre-market: 74.110.0003+0.00%05:09 EDT
Volume:1.42M
Turnover:105.44M
Market Cap:10.30B
PE:-10.32
High:74.89
Open:74.31
Low:73.52
Close:75.35
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.87
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.39
PE(LYR):-11.33

Loading ...

Cytokinetics Shares up 1.4% Premarket After Co Presents New Late-Stage Data for Heart Drug at European Society of Cardiology

THOMSON REUTERS
·
Aug 28

Cytokinetics to File FDA sNDA for Aficamten in Non-Obstructive HCM in Q4 2026

Reuters
·
Aug 28

Cytokinetics Plans to Submit Supplemental NDA to U.S. FDA for Aficamten in Q4 2026

Reuters
·
Aug 28

Cytokinetics Announces Positive Results from Acacia-HCM Presented in Hot Line Session at the European Society of Cardiology (Esc) Congress 2026 and Published in the New England Journal of Medicine

THOMSON REUTERS
·
Aug 28

Cytokinetics: Plans to Submit Supplemental Nda to U.S. FDA for Aficamten for Treatment of Adult Patients with Symptomatic Nhcm in Q4

THOMSON REUTERS
·
Aug 28

Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine

GlobeNewswire
·
Aug 28

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

TIPRANKS
·
Aug 20

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (Esc) Congress 2026

THOMSON REUTERS
·
Aug 20

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

GlobeNewswire
·
Aug 20

Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale

TIPRANKS
·
Aug 19

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares for $265,370

Reuters
·
Aug 19

Cytokinetics Grants New-Hire Equity Awards, Stock Options Priced at $74.13 Per Share

Reuters
·
Aug 19

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 19

Cytokinetics price target raised to $103 from $97 at JPMorgan

TIPRANKS
·
Aug 17

Barclays Reaffirms Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 14

Cytokinetics is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 13

Cytokinetics Files Patent Suit to Protect MYQORZO Franchise

TIPRANKS
·
Aug 13

Cytokinetics - Files Complaint Against Bristol-Myers Squibb and Myokardia - SEC Filing

THOMSON REUTERS
·
Aug 13